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Objectives: SOX9 is a transcription factor that is essential for cartilage extracellular matrix (ECM)
formation. Osteoarthritis (OA) is characterised by a loss of cartilage ECM. In chondrocytes SOX9 gene
expression is regulated by osmotic loading. Here we characterise SOX9 mRNA regulation through static
and cyclical application of hyperosmotic conditions in normal and OA monolayer equine chondrocytes.
Furthermore, we investigate whether extracellular signal-regulated protein kinase (ERK)1/2 mitogen-
activated protein kinases (MAPK) pathways have a role in this regulation of SOX9.
Methods: Equine chondrocytes harvested from normal or OA joints were subjected to different osmotic
loading patterns as either primary (P0) or passaged (P2) cells. The involvement of MEKeERK signalling
was demonstrated by using pharmacological inhibitors. In addition SOX9 gene stability was determined.
Levels of transcripts encoding SOX9, Col2A1 and aggrecan were measured using qRT-PCR. De novo
glycosaminoglycan synthesis of explants was determined with 35S sulphate during static hyperosmolar
loading.
Results: MEKeERK signalling increases glycosaminoglycans (GAG) synthesis in explants. Static hyper-
osmotic conditions signiﬁcantly reduced SOX9 mRNA in normal P2 and OA P0 but not normal P0
chondrocytes. SOX9 mRNA was stabilised by hyperosmotic conditions. Cyclical loading of normal P2 and
OA P0 but not normal P0 cells led to an increase in SOX9 gene expression and this was prevented by
MEK1/2 inhibition.
Conclusions: The response to osmotic loading of SOX9 mRNA is dependent on the nature of the osmotic
stimulation and the chondrocyte phenotype. This variation may be important in disease progression.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd.
Open access under the Elsevier OA license. Introduction
The surfaces of long bones within diarthrodial joints are lined
with articular cartilage, an avascular connective tissue that
provides a nearly frictionless bearing surface for transmitting and
distributing mechanical loads between the bones of the skeleton1.
The unique load bearing properties of articular cartilage are
dependent upon its structural composition and organisation,
particularly the interactions between collagens and proteoglycans
(PGs) within the extracellular matrix (ECM)2. These matrix
macromolecules are turned over by chondrocytes embedded
within the cartilage. Chondrocytes utilise physical signals, such as
mechanical loading and their osmotic environment3, to regulateo: Mandy Peffers, Musculo-
eterinary Teaching Hospital,
ers), pmilner@liverpool.ac.uk
iverpool.ac.uk (P.D. Clegg).
ternational. Published by Elsevier Ltheir metabolic activity. During loading, water is expressed from
articular cartilage causing the matrix to deform and the PG and
mobile cation concentration increase, exposing the chondrocytes to
a hyperosmotic environment. Thus physiologically, load-bearing
cartilages experience changes in extracellular ion composition and
hence osmotic pressure under cyclic and static loading4.
Progressive degeneration of articular cartilage leads to joint pain
and dysfunction that is clinically identiﬁed as osteoarthritis (OA). In
healthy tissue there is equilibrium between matrix deposition and
degradation; which is disrupted in OA leading to the progressive
loss of important matrix components such as collagens and PGs5. In
early OA, disruption of the collagen network results in an increase
in water content of the tissue and a corresponding decrease in
pericellular osmolarity6. PG loss in later stage OA further exacer-
bates osmotic perturbations resulting in a decrease in interstitial
osmolarity7. Under loading OA chondrocytes are subjected to
greater variations in osmolarity than normal chondrocytes due to
an increase in the rate and extent of ﬂuid loss in this swollen
cartilage8.td. Open access under the Elsevier OA license. 
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been examined in a number of studies with differing outcomes.
These studies have shown that PG synthesis can be reduced in the
presence of hyper-, or hypo-osmotic conditions9,10. A reduction in
COL2A1 gene expression has also been identiﬁed as a consequence
of hyperosmotic conditions11. A further study demonstrated that
the application of dynamic hypo-osmotic conditions caused an
upregulation in speciﬁc cartilage ECM genes12. The mitogen-acti-
vated protein kinases (MAPK); extracellular signal-regulated
protein kinase (ERK) and p38 mitogen-activated protein kinase
(p38 MAPK) have been implicated in the adaptive responses of
chondrocytes to hyperosmotic conditions9. The MAPK families are
a cell signalling transduction pathway which connects extracellular
signals to intracellular responses such as gene expression in
eukaryotic cells13. Both p38 MAPK and Jun N-terminal Kinase (JNK)
signalling pathways have previously been implicated in osmotic
stress signalling in studies in yeast and many mammalian cells14,15.
SOX9 is an essential transcription factor controlling the
expression of many cartilage ECM genes including collagen type II16
and aggrecan17. Campomelic dysplasia, a severe syndrome caused
by inadequate cartilage formation during development, is due to
a haploinsufﬁciency of SOX9 and underlines its importance to the
chondrocyte phenotype18. One of the mechanisms responsible for
the control of SOX9 expression in chondrocytes is the p38 MAPK-
dependant regulation of its mRNA stability11. We recently demon-
strated that human articular chondrocytes (HAC) exposed to
hyperosmotic culture increased the stability of SOX9 mRNA,
a process which was also sensitive to p38 MAPK inhibition11.
There is no data that determines the effect of hyperosmotic
loading on normal vs OA chondrocytes, which are known to
undergo changes in phenotype. This study compares the response
to hyperosmotic loading of cultured normal and OA primary (P0)
chondrocytes. Cell therapy and tissue engineering have the
potential to become important treatments in human articular
repair but suffer a major limitation, as chondrocytes in vitro lose the
differentiated phenotype. Thus we wished to identify whether the
altered phenotype demonstrated in passaged (P2) chondrocytes
effects SOX9 gene expression during hyperosmotic loading. The
response of articular cartilage to loading is a complex. Therefore
models in which individual physical phenomena can be studied
separately are important in determining the cellular mechanisms of
joint loading. Our present study was performed to explore the
effects of osmolarity on SOX9 expression and the biosynthetic
response, by examining whether the activation of the ERK signal-
ling pathways were required. As data from compressive loading
experiments clearly indicate that dynamic compression of cartilage
produces increases in ECM synthesis by chondrocytes19 we also
examined the nature of the osmotic load applied to cells.
Method
Chondrocyte isolation, expansion and culture
Equine articular cartilage was obtained from the surfaces of
metacarpophalangeal joints of skeletally mature horses with
grossly normal or arthritic joints. OA joints were derived from
clinically diagnosed cases following euthanasia, which on gross
pathological inspection exhibited patterns typical of late OA
including cartilage ﬁbrillation and erosion, and had disease diag-
nosed pre-mortem to that joint using clinical methods. Sample
collection was subject to institutional ethical review. Isolation of
articular chondrocytes has been described previously20. The equine
articular chondrocytes (EAC) (n¼ 3) were grown as monolayers in
Dulbecco’s modiﬁed eagles medium (DMEM) (Invitrogen, Paisley,
UK), supplemented with 10% foetal calf serum (FCS), 100 units/mlpenicillin, 100 mg/ml streptomycin (all from Invitrogen, Paisley, UK)
and 500 ng/ml amphotericin B (BioWhittaker, Lonza, USA). Exper-
iments were undertaken with either freshly isolated EAC plated at
100,000 cells/cm2 and used within 48 h, or with EAC plated at
20,000 cells/cm2 and grown through two passages (with a 1:2 split
ratio). In order to elucidate the effects of medium osmolarity on the
cells they were grown for 5 h in serum-free and antibiotic-free
DMEM adjusted with NaCl to yield 380mOsm or 550mOsm solu-
tions. Previouslywe conﬁrmed that the effects on SOX9mRNAwere
due to the osmotic environment and not caused by increased
sodium levels11. Following production of the deﬁned media
a freezing point depression osmometer (Loser, Berlin, Germany)
was used in order to conﬁrm, the osmolarity was within an
acceptable range of 2% variation. Osmolarities used were based
upon previous experiments which examined the effects of osmo-
larity on chondrocytes where 380mOsm control conditions are
close to those experienced by healthy chondrocytes in-situ, and
550mOsm represented a hyperosmotic condition9,11,27. We have
recently shown that actin stress ﬁbre formation impaired the
response of passage 2 HAC to hyperosmotic load11. Therefore
passage 2 EAC cultures were supplemented with 10 mM of the
ROCK1/2 inhibitor Y27632 (Calbiochem, Nottingham, UK). Where
necessary, cultures were also cultured with 10 mM of the MEK1/2
inhibitor U0126 (Sigma-Aldrich, Dorset, UK), for 2 h prior to the
commencement of experiments.
Gene expression analysis
Total RNA was prepared from monolayer cultures in 12-well
culture plates using 0.5 ml Tri Reagent (Ambion, Warrington, UK)
per well. The Guanidinium thiocyanateephenolechloroform
extraction technique was used as previously described21. M-MLV
reverse transcriptase and random hexamer oligonucleotides were
used to synthesize cDNA from RNA (both from Promega, South-
ampton, UK) in a 25 ml reaction. 1 ml aliquots were ampliﬁed by PCR
in 20 ml reaction volumes on an ABI 7700 Sequence Detector using
either a SYBR Green PCR mastermix or a Taqman mastermix where
appropriate (Applied Biosystems, Warrington, UK). The ﬁtness of
GAPDH as a valid normalisation factor under different osmolarities
has been previously established by us11. Relative expression levels
were normalised to GAPDH and calculated using the 2DCt
method22. Primers and probes for equine SOX9 and GAPDH were
designed by Applied Biosystems Assays-by-Design and had the
following sequences: SOX9 Forward; CGC-CGA-AGC-TCA-GCA-AGA,
Reverse; CGC-TTC-TCG-CTC-TCG-TTCA, Probe; CAA-GCT-CTG-GAG-
ACT-GC; GAPDH Forward; ACT-GGT-GTC-TTC-ACT-ACC-TTG-GA,
Reverse; AGC-AGA-GAT-GAT-GAC-CCT-TTT-GG; Probe; AAG-TGA-
GCC-CCA-GCC-TT. For determination of aggrecan and COL2A1, SYBR
Green detection was used and primers were obtained from Euro-
gentec (Seraing, Belgium). The primer sequences for aggrecanwere
designed in Primer Express (Applied Biosystems) software and
were: Forward; AGG-AGC-AGG-AGT-TTG-TCA-ACA; Reverse; CCC-
TTC-GAT-GGT-CCT-GCT-AT. The primer sequence for COL2A1 and
for the housekeeping gene GAPDHhave beenpreviously reported23.
All primers used were designed across exon boundaries.
RNA decay analysis
For decay experiments freshly isolated EAC (n¼ 4) were grown
in monolayers and treated under experimental conditions for 2 h
before the addition of 1 mM of the transcription inhibitor actino-
mycin D (Sigma-Aldrich, Dorset, UK). Decay of SOX9 was then
measured following extraction of puriﬁed total mRNA at a number
of time points 0e3 h later. This was reverse transcribed and real-
time PCR undertaken; decay curveswere generated using GAPDH as
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Fig. 1. Effect of static hyperosmotic loading on matrix gene expression. Col2A1 and
aggrecan mRNA levels in monolayer culture of freshly isolated normal (P0), normal P2
and OA P0 EAC which were incubated at 380 or 550mOsm for 5 h. Data are represented
as fold change in expression compared to cells under 380mOsm. Histograms represent
means 95% CI. # P< 0.01, * P< 0.05 compared to 380mOsm (represented by dashed
line). Data were evaluated using mixed effect linear regression (n¼ 3, three technical
replicates per observation).
M.J. Peffers et al. / Osteoarthritis and Cartilage 18 (2010) 1502e15081504a normalisation factor. Data was plotted on semi-log charts and
exponential regression lines generated inMicrosoft Excel. The slope
(m) of the regression lines were used to calculate themRNA half-life
(t1/2) using the equation t1/2¼ ln(2)/m in order to examine stability.
Quantiﬁcation of PG
Glycosaminoglycans (GAG) synthesis was quantiﬁed by
measuring the incorporation of radioactive 35S sulphate. Cartilage
explants were from skeletally mature grossly normal meta-
carpophalangeal joints of horses. Full thickness cartilage was
excised and cut into 3 mmdiameter explants from the entire surface
of the proximal phalanx (n¼ 3). The explantswere blotted on sterile
gauze pads and their wet weight was recorded. They were then
transferred into DMEM supplemented with 10% FCS, 100 units/ml
penicillin, 100 mg/ml streptomycin and 500 ng/ml amphotericin B
andmaintained in 12-well culture plates for 48 h at 37C in a 5% CO2
incubator, to allow synthetic activity to reach equilibrium after
harvesting24. To evaluate the effect of osmotic loading and
MEKeERK signalling on de novo GAG synthesis cartilage explants
were labelled in DMEM adjusted to 380 or 550mOsm with NaCl,
containing 2 mCi/ml of 35S sulphate (MP Biomedicals Inc, Irvine, USA)
and, where appropriate, with the MEK1/2 inhibitor U0126 (10 mM).
Labelling was performed over 24 h. Sulphate incorporation was
determined following papain digestion of the explants25. Unincor-
porated radiolabel was separated frommacromolecular products in
all samples using PD-10 size exclusion columns (GE Healthcare
Lifesciences, Amersham, UK) and eluted in phosphate-buffered
saline (Sigma-Aldrich, Dorset, UK)26. The 35S sulphate radioactivity
was measured by liquid-scintillation counting (1410 liquid-scintil-
lation counter; Wallac Oy, Finland) of aliquots from void volume
fractions. Total sulphate incorporation rate was calculated for the
35S sulphate incorporation rate and normalised to wet weight.
Statistical analysis
Following normality testing statistically signiﬁcant differences
for t1/2 data, GAG synthesis and gene expression values of control
and treated cultures were analysed using mixed effects linear
regression to allow for donors with signiﬁcant biological variation.
Where data are represented as mean values a 95% conﬁdence
interval (CI) is used. The analyses were undertaken using S-Plus,
SPSS, Minitab and Excel software.
Results
Effect of hyperosmolar loading on ECM synthesis
We were interested in the effect of medium osmolarity on ECM
production and whether MEKeERK signalling had a role. Therefore
we examined de novo GAG synthesis by 35S sulphate incorporation
in equine cartilage explants cultures. Following 24-h culture at
550mOsm there was an increase in GAG synthesis compared to
380mOsm (19%) but this did not reach statistical signiﬁcance.
Interestingly the presence of the MEK1/2 inhibitor U0126 signiﬁ-
cantly reduced the incorporation of 35S sulphate in both osmotic
conditions (P¼0.04). There was a trend for a multivariable rela-
tionship and an interaction between osmolarity and U0126
(P¼ 0.06, P¼ 0.09 respectively). These results suggest that
MEKeERK signalling increases GAG synthesis.
Matrix gene expression in isolated cells
Next, to deﬁne further the downstream effects of static hyper-
osmolar loading on normal and OA chondrocytes in monolayerculture, we investigated the expression of the cartilage matrix genes
COL2A1 and aggrecan, downstream targets of SOX9. Overall we
demonstratedasmallbut signiﬁcanteffectofhyperosmotic conditions
on the expression of these genes in dedifferentiated chondrocytes.
There was a reduction in COL2A1 mRNA in normal P2 chondrocytes
(3 fold 0.3 SD, P¼ 0.045) whilst OA P0 chondrocytes exhibited an
increase in aggrecanmRNA (3 fold 1.7 SD, P¼0.05) (Fig. 1).
Effect of actin stress ﬁbres on SOX9 gene expression in P2 EAC
Previously we identiﬁed an inhibitory role for actin stress ﬁbres
during hyperosmotic induction of SOX9 in HAC. To examine this
further in EAC monolayer cultures of passage 2 EAC, derived from
healthy cartilage were incubated in 380mOsm or 550mOsm media
for 5 h in the presence or absence of the ROCK1/2 inhibitor Y27632
(10 mM). Analysis of SOX9 mRNA levels in these cultures showed
that the ROCK inhibitor Y27632 had no signiﬁcant effect in cultures
exposed to a 5-h period of static hyperosmolar loading [Fig. 2(a)].
Therefore the healthy P2 EAC demonstrated different characteris-
tics to the OA HAC previously examined.
Effect of hyperosmotic loading on SOX9 gene expression
Freshly isolated EAC from normal or OA joints or passage 2 EAC
from normal joints were exposed to static hyperosmolar loading of
550mOsm for a 5-h period in order to determine the effect of
hyperosmotic stress on SOX9mRNA expression. Culturemediawith
an osmolarity of 380mOsm was used as the control condition.
Although a 50% reduction in SOX9 mRNA in normal P0 chon-
drocytes subjected to static hyperosmolar loading was evident
[Fig. 2(b)]; this reduction was not statistically signiﬁcant. In
contrast, in P2 normal and P0 OA chondrocytes static hyperosmotic
loading signiﬁcantly reduced SOX9 mRNA [Fig. 2(b)] (65%
P¼ 0.0004, 55% P¼ 0.0096).
Examining the role of ERK in hyperosmotic loading
Wewished to ascertain whether ERK signalling had an effect on
SOX9 gene expression in EAC exposed to hyperosmotic loading. In
normal P0 EAC, MEK1/2 inhibition with U0126 signiﬁcantly
reduced SOX9 mRNA under both normosmolar and hyperosmolar
conditions (50% and 80% respectively, P¼0.0003) [Fig. 2(b)]. This
reduction was not seen in P2 normal chondrocytes or P0 OA EAC.
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Fig. 2. (a) Effect of the ROCK inhibitor Y27632 on SOX9 gene expression in passage 2
EAC. Real-time PCR analysis of SOX9 mRNA in monolayer cultures of cultures exposed
to 380mOsm or 550mOsm for 5 h in the absence or presence of the ROCK1/2 inhibitor
Y27632. Data are represented as fold change in expression compared to cells under
380mOsm with no inhibitor. Histograms represent means 95% CI. Data were evalu-
ated using mixed effect linear regression (n¼ 3, three technical replicates per obser-
vation) and no statistical signiﬁcance was evident in any condition. (b) Effect of static
hyperosmotic loading and the MEK1/2 inhibitor U0126 on SOX9 mRNA levels in EAC.
Freshly isolated normal P0, normal P2 and OA P0 were chondrocytes cultured at 380 or
550mOsm in the presence or absence of the MEK1/2 inhibitor U0126 for 5 h. Data are
represented as the fold change in expression compared to 380mOsm cultures without
U0126 (represented by the dashed line). Histograms represent means 95% CI. #
P¼ 0.0096, w P< 0.001 compared to 380mOsm control. (n¼ 3, three technical repli-
cates per observation, mixed effects linear regression).
Fig. 3. Actinomycin D chase analysis to examine decay of SOX9 mRNA in freshly iso-
lated normal EAC. RNA decay curves are presented for cells cultured at 380mOsm alone
or 550mOsm. Data represents the means and 95% CI of the fold changes in SOX9 levels
compared to time point zero for four donors, three technical replicates per observation.
Slopes of the lines are shown on the graph.
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M.J. Peffers et al. / Osteoarthritis and Cartilage 18 (2010) 1502e1508 1505Previously we found in HAC derived from OA tissue that hyper-
osmotic conditions led to an increase in the half-life of SOX9
mRNA11. Decay curves generated using mean values for all donors
identiﬁed that culture of normal P0 EAC in 550mOsm produced
a trend towards an increase in the stability of SOX9mRNA (P¼ 0.07)
(Fig. 3). Further analysis of the SOX9 mRNA levels at the end of the
decay study (3.5 h) revealed a signiﬁcant increase in SOX9 levels at
550mOsm (P¼ 0.005). We were interested in whether ERK1/2
affects this process but found that treatment with U0126 had no
effect on the stability of SOX9mRNA at 550mOsm (data not shown).-2
Condition
U0126
Fig. 4. Effect of cyclical hyperosmotic loading on SOX9 mRNA in EAC. SOX9 mRNA
levels in monolayer culture of freshly isolate P0, P2 normal and OA P0 EAC incubated
under constant 380mOsm, constant 550mOsm or with cyclical application of
380mOsm and 550mOsm every 30 (c30) or 60 (c60) min for the 5-h period. Experi-
ments were carried out in the presence or absence of the MEK1/2 inhibitor U0126
(10 mM). Data are represented as the fold change in expression compared to cells under
380mOsm conditions and without the inhibitor (represented by the dashed line).
Histograms represent means 95% CI. ^ P< 0.07, *P< 0.05, # P< 0.01, w P< 0.001
(n¼ 3, mixed effects linear regression, three technical replicates per observation).Effect of cyclical hyperosmotic loading on SOX9 expression
In vivo, chondrocytes subjected to periods of cyclical loading
reveal ﬂuid-ﬂow and osmotic ﬂuctuations within the tissue4.
Therefore we examined the effect of a cyclical application of
hyperosmolarity on EAC. Media was changed from 380mOsm to
550mOsm, alternating every 30 (c30) or 60 (c60) min over 5 h. At
each frequency the ﬁnal incubation period was under 550mOsm. In
P0 normal chondrocytes dynamic hyperosmolar loading had noaffect on SOX9 mRNA. However in normal P2 and OA P0 there was
an increase in SOX9 mRNA of 2e3 folds. This was only statistically
signiﬁcant for OA P0 chondrocytes when the culture media was
changed every 60 min (P¼ 0.017) though a trend was evident for
OA P0 at changes every 30 min (P¼ 0.07) (Fig. 4). We also deter-
mined the effects of ERK inhibition on EAC cultured under cyclical
hyperosmotic condition (Fig. 4). The presence of MEK1/2 inhibitors
in cultures of both normal P2 and OA P0 chondrocytes prevented
the increase in SOX9 mRNA caused by both the 30 and 60-min
cyclical loading regimes (normal P2 chondrocytes U0126; 77%;
P¼ 0.001, and OA P0 chondrocytes U0126; 50%; P¼ 0.044), (Fig. 4).
These ﬁndings indicate that the MEKeERK signalling pathway is
necessary for the elevation of SOX9 mRNA evident in cyclic
hyperosmotic loading of normal P2 and OA P0 chondrocytes.
Finally, COL2A1 and aggrecan gene expression were also investi-
gated during cyclic hyperosmotic loading experiments. No change
in the expression of these genes was evident in any of the cells or
experimental conditions (data not shown).Discussion
In chondrocytes some of the changes in matrix expression in
response to osmolarity have been well studied9,27 however, less is
known about these changes in OA chondrocytes. The expression of
M.J. Peffers et al. / Osteoarthritis and Cartilage 18 (2010) 1502e15081506SOX9 is essential for the ability of the chondrocyte to produce
a cartilage matrix28 and so we were interested in investigating the
expression of SOX9 in normal and OA chondrocytes under osmotic
loading, which has been previously un-documented. Given the
importance of SOX9 in the development and maintenance of the
chondrocyte phenotype, its reduction in OA28,29 may contribute to
the cartilage pathology. Mechanical stimulation of chondrocytes
induces numerous physicochemical changes including alterations
in osmotic pressure30. This produces a number of physiological and
biochemical responses resulting in changes in expression of matrix
genes. The nature of the response, in part, depends on the nature of
the mechanical stimulation. In general, dynamic stimuli results in
an anabolic response, whereas static compression more frequently
inhibits chondrocyte activity31. The response of chondrocytes from
OA cartilage is signiﬁcantly different from that of normal chon-
drocytes32 suggesting that altered sensing of the osmotic envi-
ronment and inappropriate responses of the resident chondrocyte
population may be important in disease progression.
Previously static hyperosmotic loading for 5 h of P2 HAC derived
from OA joints of patients undergoing total knee arthroplasty
resulted in an increase in SOX9 mRNA11. Contrastingly, here we
were intrigued to ﬁnd that in EAC there was a reduction in SOX9
mRNA although this was only signiﬁcant in normal P2 and OA P0.
During expansion of normal chondrocytes and in OA chondrocytes
there is a loss of the speciﬁc chondrocytic phenotype and a rever-
sion to a more ﬁbroblast-like phenotype33e35. This process appears
to alter the response of chondrocytes to a change in osmolarity.
However, similar to HAC there was also an increase in the stability
of SOX9 mRNA in hyperosmotic conditions11. This latter ﬁnding
would suggest that more SOX9 mRNA should be present. In yeast
hyperosmotic stress represses the transcription of the glucose
transporter genesHXT2 and HXT4, although there is an increase in
transcript half-life36 and the effect evident here may be similar
resulting in a reduction in the transcription of SOX9 in EAC under
hyperosmotic loading. Further studies using nuclear run-on
assays37, would need to be undertaken to investigate whether this
is indeed the case. Interestingly there is an increase in SOX9 during
cyclic hyperosmotic loading in normal P2 and OA P0 but not normal
P0 chondrocytes, which is in agreement with our ﬁndings in HAC
OA P2 chondrocytes (unpublished data). These data suggest that
there is only an effect on SOX9 mRNA amounts through both static
and cyclic hyperosmotic loading on chondrocytes with altered
phenotype, from either culture dedifferentiation or phenotypic
alteration from disease in equine tissue. Modiﬁcations of the
articular chondrocyte phenotype are commonly observed in OA
cartilage, including suppression of genes involved in the pheno-
typic stability of articular chondrocytes38, reduced ECM protein
production39, proliferation and change in morphology40. During
expansion of normal chondrocytes and in OA chondrocytes there is
a loss of chondrocytic phenotype and a reversion to a more ﬁbro-
blast-like phenotype35. This phenotypical change is accompanied
by decreased gene expression of cartilage speciﬁc markers like
COL2A1 and aggrecan. This process could also alter the response of
chondrocytes to extracellular stimuli such as a change in osmo-
larity. In normal HAC cyclic stretch has an anabolic effect as shown
by increases in aggrecan expression. However, this effect was not
evident in OA chondrocytes, where no change in the expression of
either gene was observed41. This difference might be attributed to
a change in mechanotransduction pathways between normal and
OA chondrocytes42.
A previous study undertaken in bovine chondrocytes encapsu-
lated in alginate beads for 48 h indicated an increase in sulphate
incorporation in response to hyperosmotic conditions which was
abrogated in the presence of the MEK inhibitor PD980599. Here we
demonstrate that MEKeERK signalling effects GAG synthesis innormal equine cartilage explants and there is a trend for an inter-
action between osmolarity and MEKeERK signalling. We examined
aggrecan and COL2A1 levels in our cultures and found that hyper-
osmolarity had little effect on their expression in most experi-
mental conditions. However, there was a reduction in COL2A1 in
normal P2 chondrocytes agreeing with the majority of studies that
have noted a decrease in ECM production under static hyper-
osmotic loading31. Intriguingly there was an increase during static
hyperosmolar loading in aggrecan mRNA in OA P0 chondrocytes,
similar effects have been revealed in human and bovine interver-
tebral disc cells exposed to hyperosmotic conditions43. This is in
contrast to other studies in normal chondrocytes where an increase
in osmolarity results in a reduction in aggrecan mRNA27.
Many cells exist in an environment where osmolarity can ﬂuc-
tuate and have a variety of responses; these often appear to be
controlled through a signalling network of protein kinases and
transcription factors. In mammalian cells hyperosmolarity activates
many MAP kinases including ERK1/2 MAPK. In yeast cells although
ERK activity is not essential for the transcriptional regulation of
BGT1 and SMIT, genes that encode for osmolyte transporters44,
inhibition of MEK1 down regulated TonE-mediated reporter gene
expression45 and it has been proposed that the activation of ERK
pathway in hyperosmotically stressed cells serves as a cell survival
signal46. Interestingly studies on rat nucleus pulposus cells, which
produce an ECM similar to that of chondrocytes, indicated exposure
to a hyperosmotic environment resulted in an increase in the
transcription factor TonEBP with a subsequent activation of its
target genes including aggrecan. This transactivation was sensitive
to inhibition of ERK signalling47. Others have demonstrated that
MEKeERK signalling is activated in articular chondrocytes experi-
encing normal osmotic conditions, exposed to ﬂuid-ﬂow leading to
a down-regulation of aggrecan48. In the present study the elevated
response of SOX9 mRNA under cyclic hyperosmotic loading is
dependent onMEKeERK signallingwhich is comparable to ﬁndings
in HAC (unpublished data). Although MEKeERK signalling was not
required for the reduction in SOX9 apparent in static hyperosmotic
loading of normal P2 and OA P0 equine chondrocytes, in normal P0
chondrocytes blocking this pathway using the MEK1/2 inhibitor
U0126 demonstrated that MEKeERK signalling represses SOX9
expression in normal chondrocytes. Hyperosmotic stress has been
previously shown to activate ERK in tissue culture49. Furthermore
in young murine P0 chondrocytes there was an increased Sox9
expression, caused by FGF-2 stimulation which was inhibited by
U012650. These results demonstrate a similarity between the
reactions of young murine costal chondrocytes and normal equine
chondrocytes which were used in this study.
From these studies we have found that the nature of the
response to osmotic loading of SOX9 mRNA is dependent on the
nature of the osmotic stimulation and on the chondrocyte pheno-
type. The response of chondrocytes from OA cartilage is signiﬁ-
cantly different from that of normal chondrocytes suggesting that
altering sensing of the osmotic environment and inappropriate
responses of the resident cell population may be important in
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